MoneyWorks4Me

Brooks Laboratories commence commercial production at Manufacturing Unit-II, Vadodara

07 Mar 2017 Evaluate

Brooks Laboratories has commenced commercial production at its New Manufacturing Unit-II, Vadodara, Gujarat. The company’s Vadodra facility had received manufacturing licence from Commissioner of Food & Drugs Control Administration, Gandhinagar last year, valid for the period of 5 years from August 16, 2016 to August 15, 2021.

Brooks Laboratories is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Brooks Laboratories Share Price

59.50 0.17 (0.29%)
19-Aug-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1896.70
Dr. Reddys Labs. 1173.25
Cipla 1421.70
Lupin 2222.60
Zydus Lifesciences 1112.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: